SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Harsco Corporation (HSC) .
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($6.50, 29%).
- Analyst consensus target $6.50 (-29% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 21/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HSC
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.33
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.08
Book Value / Share$0.00
Revenue / Share$27.76
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$6.50 (-29%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-1.07 |
$1.45B |
$-85.67M |
-5.9% |
| 2017 |
$0.09 |
$1.61B |
$7.82M |
0.5% |
| 2018 |
$1.64 |
$1.72B |
$137.06M |
8% |
| 2019 |
$0.45 |
$1.5B |
$36.26M |
2.4% |
| 2020 |
$-0.36 |
$1.86B |
$-28.35M |
-1.5% |
| 2021 |
$0.35 |
$1.85B |
$28.42M |
1.5% |
| 2022 |
$-1.68 |
$1.89B |
$-133.34M |
-7.1% |
| 2023 |
$-1.08 |
$2.07B |
$-86.12M |
-4.2% |
| 2024 |
$-1.60 |
$2.34B |
$-127.97M |
-5.5% |
| 2025 |
$-2.08 |
$2.24B |
$-167.6M |
-7.5% |
